If a pharmaceutical company sets an unnecessarily high price for a lifesaving drug, it is behaving in a(n)_____________ manner.

When a pharmaceutical company sets an unnecessarily high price for a lifesaving drug, it demonstrates a lack of concern for the social responsibility that comes with the role of providing essential healthcare products. Pricing a lifesaving medication beyond what is fair or reasonable prioritizes profit over patient welfare, especially when individuals may not be able to afford the medication they need for survival. This behavior undermines the principles of accessibility and equity in healthcare, which are critical in the pharmaceutical industry where the impact on human lives is profound.

The concept of social responsibility involves making decisions that take into account the well-being of society as a whole. In contrast, pricing that exploits vulnerable patients for maximum profit is a clear indication of social irresponsibility. Thus, it highlights a failure to align corporate practices with ethical standards and societal expectations, reinforcing the idea that such a practice is detrimental not only to individuals in need but to the company's reputation and trust within the community.